Volume 89 Issue 51 | pp. 32-33
Issue Date: December 19, 2011

Critics Target Patent Deals

New legislation could gain support from small generic drug firms
Department: Government & Policy
Keywords: generics, patents, pharmaceuticals

An effort by some members of Congress to restrict pharmaceutical industry deals that critics charge are designed to delay the market entry of low-cost generic drugs has thus far been unsuccessful. But two senators, who aim to curb certain patent lawsuit settlements between brand-name and generic drug makers, are trying a new legislative approach.

“At a time when Americans are struggling to make ends meet, the cost of prescription medications is outpacing inflation. We need . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society